Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 8
2004 1
2005 9
2006 10
2007 11
2008 10
2009 12
2010 10
2011 8
2012 8
2013 10
2014 11
2015 11
2016 13
2017 12
2018 14
2019 16
2020 12
2021 14
2022 13
2023 26
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Results by year

Filters applied: . Clear all
Page 1
Deutsche Gesellschaft für Radioonkologie (DEGRO) mahnt stationäre strahlentherapeutische Versorgung an : Stellungnahme zu einem Urteil des Bundessozialgerichts vom 29.08.2023 zur Erbringung stationärer strahlentherapeutischer Leistungen.
Fietkau R, Höller U, van Kampen M, Krause M, Petersen C, Vordermark D. Fietkau R, et al. Among authors: vordermark d. Strahlenther Onkol. 2024 Feb;200(2):107-108. doi: 10.1007/s00066-023-02169-4. Epub 2023 Oct 23. Strahlenther Onkol. 2024. PMID: 37872397 Free PMC article. German. No abstract available.
Pediatric classical Hodgkin lymphoma.
Lo AC, Dieckmann K, Pelz T, Gallop-Evans E, Engenhart-Cabillic R, Vordermark D, Kelly KM, Schwartz CL, Constine LS, Roberts K, Hodgson D. Lo AC, et al. Among authors: vordermark d. Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28562. doi: 10.1002/pbc.28562. Pediatr Blood Cancer. 2021. PMID: 33818890 Review.
Adjuvant treatment for endometrial cancer.
Emons G, Vordermark D. Emons G, et al. Among authors: vordermark d. Curr Opin Oncol. 2019 Sep;31(5):404-410. doi: 10.1097/CCO.0000000000000558. Curr Opin Oncol. 2019. PMID: 31233482 Review.
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.
Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajić V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH. Mauz-Körholz C, et al. Among authors: vordermark d. Lancet Oncol. 2022 Jan;23(1):125-137. doi: 10.1016/S1470-2045(21)00470-8. Epub 2021 Dec 9. Lancet Oncol. 2022. PMID: 34895479 Free PMC article. Clinical Trial.
Radiotherapy of Cervical Cancer.
Vordermark D. Vordermark D. Oncol Res Treat. 2016;39(9):516-20. doi: 10.1159/000448902. Epub 2016 Aug 18. Oncol Res Treat. 2016. PMID: 27614991 Review.
S2k-Leitlinie - Merkelzellkarzinom - Update 2022.
Becker JC, Beer AJ, DeTemple VK, Eigentler T, Flaig MJ, Gambichler T, Grabbe S, Höller U, Klumpp B, Lang S, Pföhler C, Posch C, Prasad V, Schlattmann P, Schneider-Burrus S, Ter-Nedden J, Terheyden P, Thoms K, Vordermark D, Ugurel S. Becker JC, et al. Among authors: vordermark d. J Dtsch Dermatol Ges. 2023 Mar;21(3):305-317. doi: 10.1111/ddg.14930_g. J Dtsch Dermatol Ges. 2023. PMID: 36929546
Cardiotoxicity and oncological treatments.
Schlitt A, Jordan K, Vordermark D, Schwamborn J, Langer T, Thomssen C. Schlitt A, et al. Among authors: vordermark d. Dtsch Arztebl Int. 2014 Mar 7;111(10):161-8. doi: 10.3238/arztebl.2014.0161. Dtsch Arztebl Int. 2014. PMID: 24666651 Free PMC article. Review.
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.
Mauz-Körholz C, Landman-Parker J, Fernández-Teijeiro A, Attarbaschi A, Balwierz W, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Ceppi F, Claviez A, Daw S, Dieckmann K, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajić V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH, Kluge R. Mauz-Körholz C, et al. Among authors: vordermark d. Lancet Oncol. 2023 Mar;24(3):252-261. doi: 10.1016/S1470-2045(23)00019-0. Lancet Oncol. 2023. PMID: 36858722 Free article. Clinical Trial.
230 results